Most T2DM patients have MetS but it is uncommon in T1DM. Despite treatment, almost half of patients still met the criteria for MetS. Aggressive treatment of MetS components is required to reduce cardiovascular risk in DM.

Anaemia was relatively common in patients attending for routine outpatient diabetes clinic review. The high prevalence of anaemia supports the routine screening for anaemia in the diabetes out-patient clinic, including in those without overt nephropathy.

The aim of this study was to determine the effectiveness of annual screening for hypothyroidism requiring thyroxine treatment (HRTT) in a hospital‐based diabetes clinic.A retrospective study of case records of patients attending a hospital‐based diabetes clinic was undertaken. Random samples of 400 patients with type 1 diabetes and 400 patients with type 2 diabetes were included. Patient data including thyroid function tests and thyroxine use were recorded. The outcomes were the prevalence of HRTT, and the cost‐per‐diagnosis of screening for HRTT in the diabetes clinic.Type 1 diabetes patients were younger (41 vs 60 years, p<0.001) and their diabetes was of longer duration (median 9.5 vs 5 years, p<0.05) than those with type 2 diabetes. Hypothyroidism was common in patients with type 1 (10.8%) or type 2 diabetes (10.8%). The prevalence of HRTT was 6.8% in type 1 diabetes and 6.0% in type 2 diabetes, with the majority being female (81% and 83%). The prevalence of HRTT increased after 50 years of age in type 1 diabetes, and somewhat later in type 2 diabetes, in the over 60s reaching 18.8% in type 1 diabetes and 8.4% in type 2 diabetes. Annual screening detected one case of HRTT for every 470 blood tests, equating to £4600 per diagnosis.In conclusion, hypothyroidism was common in patients with type 1 or type 2 diabetes who attended a hospital‐based diabetes clinic. However, annual screening at the hospital clinic only rarely found new cases of HRTT, and so is questionable from a cost:benefit viewpoint. Copyright © 2010 John Wiley & Sons.

We aimed to assess the utility and acceptability of outpatient glucose self‐monitoring in an adult cystic fibrosis (CF) population.Adults with CF were asked to self‐monitor their capillary glucose, three times per day for two weeks preceding their hospital outpatient appointment. The American Diabetes Association definition of dysglycaemia was used, defined by at least two elevated glucose recordings of fasting glucose ≥5.6mmol/L or post‐prandial glucose ≥7.8mmol/L.From a CF population of 43 patients, 10 were excluded (mainly due to clinic in‐attendance). Of the remaining 33 patients, 29 (88%) consented to perform glucose self‐monitoring, and 22 patients (67% of eligible patients and 76% of those consenting to take part) provided glucose data. Dysglycaemia was found in 19 of 22 patients (86%).We conclude that glucose self‐monitoring in the weeks prior to outpatient CF clinic review could become the preferred tool for screening and monitoring of dysglycaemia in adult CF. Copyright © 2011 John Wiley & Sons.

No abstract